Silvia Damaso

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 5

Top Topics

Systemic Lupus Erythematosus

Clinical Decision Support

Top Venues

Human vaccines & immunotherapeutics

Asian biomedicine : research, reviews and news

This page only lists publications with an associated author ORCID identifier.

Publications

Maria Rosario Capeding, Melanie de Boer, Silvia Damaso, Adrienne Guignard
Assessing the burden of dengue among household members in Alaminos, Laguna, the Philippines: a prospective cohort study. Asian biomedicine : research, reviews and news 15 (5) (2021)
Gaël Dos Santos, Bach-Yen Nguyen, Silvia Damaso, Lode Godderis, Xavier Martínez-Gómez, Tamara Eckermann, Hugo Loos, Ignacio Salamanca de la Cueva, Vishvesh Shende, Alexander C Schmidt, Anne Yeakey
Brand-Specific Enhanced Safety Surveillance of GSK's Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain for the 2018/2019 Season. Drug safety 43 (3) (2020)
Simon de Lusignan, Silvia Damaso, Filipa Matos Ferreira, Rachel Byford, Christopher McGee, Sameera Rankiri Pathirannehelage, Vishvesh Shende, Ivelina Yonova, Alexander C Schmidt, Anne E Schuind, Gaël Dos Santos
Brand-specific enhanced safety surveillance of GSK's Fluarix Tetra seasonal influenza vaccine in England: 2017/2018 season. Human vaccines & immunotherapeutics 16 (8) (2020)
Dan Bi, Dan Apter, Tiina Eriksson, Mari Hokkanen, Julia Zima, Silvia Damaso, Maaria Soila, Gary Dubin, Matti Lehtinen, Frank Struyf
Safety of the AS04-adjuvanted human papillomavirus (HPV)-16/18 vaccine in adolescents aged 12-15 years: end-of-study results from a community-randomized study up to 6.5 years. Human vaccines & immunotherapeutics 16 (6) (2019)
Simon de Lusignan, Filipa Matos Ferreira, Silvia Damaso, Rachel Byford, Sameera Rankiri Pathirannehelage, Anne Yeakey, Ivelina Yonova, Anne E Schuind, Gaël Dos Santos
Enhanced passive surveillance of influenza vaccination in England, 2016-2017- an observational study using an adverse events reporting card. Human vaccines & immunotherapeutics 15 (5) (2019)